Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:IPO NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIPORenaissance IPO ETF$44.90+0.7%$43.82$31.20▼$48.23$142.70M1.2238,284 shs28,098 shsTEMTempus AI$60.65+1.1%$63.06$31.36▼$91.45$10.38BN/A7.67 million shs10.35 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIPORenaissance IPO ETF+0.74%+0.99%+2.84%+24.93%+7.80%TEMTempus AI+1.13%+1.76%-13.49%+50.06%+52.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/AN/AN/ATEMTempus AI1.417 of 5 stars2.32.00.00.01.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIPORenaissance IPO ETF 2.68Moderate Buy$44.90N/ATEMTempus AI 2.50Moderate Buy$65.097.32% UpsideCurrent Analyst Ratings BreakdownLatest IPO, QLT, TEM, and SSON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $70.005/20/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $68.005/15/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $70.005/9/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $65.005/7/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.004/24/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.004/21/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$60.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/ATEMTempus AI$693.40M15.14N/AN/A$0.35 per share173.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIPORenaissance IPO ETFN/AN/A35.63∞N/AN/AN/AN/AN/ATEMTempus AI-$705.81M-$7.80N/AN/AN/A-88.27%-533.21%-66.19%8/5/2025 (Estimated)Latest IPO, QLT, TEM, and SSON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025TEMTempus AI-$0.23N/AN/AN/A$296.84 millionN/A5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIPORenaissance IPO ETF$0.160.36%N/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIPORenaissance IPO ETFN/AN/AN/ATEMTempus AI2.451.711.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIPORenaissance IPO ETFN/ATEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipIPORenaissance IPO ETFN/ATEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIPORenaissance IPO ETFN/A3.20 millionN/ANot OptionableTEMTempus AI2,400173.12 million125.34 millionN/AIPO, QLT, TEM, and SSON HeadlinesRecent News About These CompaniesTempus AI (NASDAQ:TEM) Trading 1.8% Higher - Should You Buy?July 17 at 6:37 PM | marketbeat.comTEM Shares Surge on New AI Breakthrough: Should Investors Jump In?July 17 at 4:01 PM | zacks.comTempus gets FDA OK for software to detect cardiac issueJuly 17 at 2:07 PM | chicagobusiness.comCTempus AI, Inc. (TEM) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 17 at 12:00 PM | prnewswire.comTempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal CancerJuly 17 at 10:43 AM | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 17 at 10:00 AM | prnewswire.comFDA grants 510(k) clearance for Tempus AI’s ejection fraction softwareJuly 17 at 9:05 AM | finance.yahoo.comBrown Advisory Inc. Invests $209,000 in Tempus AI, Inc. (NASDAQ:TEM)July 17 at 3:34 AM | marketbeat.comFrom Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in MedicineJuly 16 at 11:04 PM | tmcnet.comTEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMJuly 16 at 10:32 PM | globenewswire.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the FirmJuly 16 at 7:39 PM | globenewswire.comTempus AI stock rises after FDA clearance for heart monitoring softwareJuly 16 at 6:03 PM | investing.comTempus AI Stock Is Rising Wednesday: What's Happening?July 16 at 6:03 PM | benzinga.comTempus AI shares climb after FDA approval of heart monitoring softwareJuly 16 at 6:03 PM | msn.comTempus AI, Inc. (TEM) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 16 at 4:02 PM | prnewswire.comTempus AI (NASDAQ:TEM) Trading Up 4.5% - What's Next?July 16 at 1:53 PM | marketbeat.comTempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF SoftwareJuly 16 at 8:00 AM | businesswire.comTempus AI, Inc. (NASDAQ:TEM) Stock Holdings Lessened by Dakota Wealth ManagementJuly 16 at 6:08 AM | marketbeat.comCwm LLC Increases Holdings in Tempus AI, Inc. (NASDAQ:TEM)July 16 at 4:54 AM | marketbeat.comTEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMJuly 15 at 10:25 PM | globenewswire.comTEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 15 at 4:00 PM | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?Chime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthAeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionBy Dan Schmidt | July 2, 2025View Aeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionChipotle: Too Spicy for Smart Money to Resist After Stock SplitBy Jeffrey Neal Johnson | July 11, 2025View Chipotle: Too Spicy for Smart Money to Resist After Stock SplitIPO, QLT, TEM, and SSON Company DescriptionsRenaissance IPO ETF NYSEARCA:IPO$44.90 +0.33 (+0.74%) Closing price 07/17/2025 04:10 PM EasternExtended Trading$44.82 -0.09 (-0.19%) As of 07/17/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Renaissance IPO ETF (IPO) is an exchange-traded fund that is based on the FTSE Renaissance IPO index. The fund tracks a market cap-weighted index of recent US-listed IPOs. The fund acquires issues within 90 days or sooner after IPO and sells after 3 years. IPO was launched on Oct 14, 2013 and is managed by Renaissance.Tempus AI NASDAQ:TEM$60.65 +0.68 (+1.13%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$60.79 +0.14 (+0.23%) As of 07/17/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
